- Price is above Fair Value, showing premium demand versus the model.
- Volume is elevated versus the 13-week average, confirming attention.
INDRAMEDCO
NSI
Week ended 07 Aug 2026
Weekly Investor Report
Indraprastha Medical Corporation Limited · Healthcare · Medical Care Facilities
Latest close
380.6 INR
3.9%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -2.5% below the Trend Line and sits at 12.9% of its 52-week range. The latest completed week returned 3.9%, after a -0.1% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 50/100.
Setup score
35
out of 100
Latest Close
380.6 INR
7 Aug 2026
1W Return
3.9%
latest completed week
4W Return
-0.1%
short-term follow-through
12W Return
3.5%
quarterly tape
Trend Breadth
34.6%
18 of 52 weeks active
Volume Ratio
6.4x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Activity pressure is negative, which weakens the current setup.
- Next-week expectancy is negative at 38.80% based on similar historical setup states.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
3.9%
Latest completed week; four-week move -0.1%.
Indicator stack
19/40
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 38.80%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
19 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -2.5% below the Trend Line and sits at 12.9% of its 52-week range. The latest completed week returned 3.9%, after a -0.1% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 6.4x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0312-week average 0.09
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure3/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.03Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -0.1% over four weeks, 3.5% over 12 weeks, and -14.7% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year18
Trend breadth34.6%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.31Latest activity-pressure read.
Pressure change-52.9%Four-week change in activity pressure.
Leadership-11.60Latest relative-leadership reading.
RS change-0.8%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive.
Factor week 09 Aug 2026
Financial statements through 31 Mar 2026
Field coverage 94%
Model confidence 88%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength81/100Blend of value, momentum, and quality. Underlying universe rank 20; rank 1 is best.
Value70/100Relative valuation strength. Underlying universe rank 31; rank 1 is best.
Quality91/100Profitability and accounting quality. Underlying universe rank 10; rank 1 is best.
Momentum25/100Medium-term price momentum. Underlying universe rank 76; rank 1 is best.
Growth38/100Revenue and earnings growth. Underlying universe rank 63; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Value-quality framework78/100Value and quality alignment from the Sharemaestro SVQF framework.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 19.9x Price divided by trailing earnings.
- Price / sales
- 2.4x Market value relative to trailing revenue.
- EV / EBITDA
- 12.4x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- 3.1% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 36.7% Gross profit retained from each unit of revenue.
- Operating margin
- 14.9% Operating profit retained from revenue.
- Free-cash-flow margin
- 7.5% Free cash flow generated from revenue.
- Return on invested capital
- 20.7% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 9.3% Latest one-year revenue growth.
- EPS growth
- 14.1% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- -10.5% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 6/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- 1.2% Cash dividends relative to market value.
- Buyback yield
- 0.0% Net share repurchases relative to market value.
- Shareholder yield
- 1.2% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 0.1x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 19 relevant articles.
3 positive · 16 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-40.6%Distance below the 52-week high.
13-week volatility4.6%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher11 of 2615 weeks finished lower.
Best week+10.4%Week of 13 Feb.
Worst week-13.5%Week of 15 May.
Latest week+3.9%Week of 7 Aug.
Shape of recent returns
Strong gains5
Modest gains6
Flat weeks0
Modest losses12
Sharp losses3
Recent vol4.6%13-week weekly-return volatility.
Base vol6.0%52-week weekly-return volatility.
Up/down split21/31Count of positive and negative weeks in the 52-week window.
Average skew5.1% / -3.7%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorIN Healthcare
4-week rank51 / 100
Group average1.2%
Trend breadth83.0%
Trend83.0%active weekly trend signals
MD85.0%positive activity pressure
RS73.0%positive relative leadership
Four-week leaders
IndustryIN Medical Care Facilities
4-week rank16 / 21
Group average2.1%
Trend breadth85.7%
Trend85.7%active weekly trend signals
MD76.2%positive activity pressure
RS61.9%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape31/100
Trend, activity pressure, participation, and risk combine to a 31/100 tape read.
Indicator analysis14/100Latest 12-week confirmation: trend 0/12, activity pressure 3/12, relative leadership 0/12.
Activity pressure 0.03; No reversal markers Next-Week ExpectancyNegative 38.80%Next-week expectancy is negative with a 38.80% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors68/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 39; Small Cap Core rank 41 SVQF78/100Value and quality alignment from the Sharemaestro SVQF framework.
Composite rank 346.0 of 1576 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 19 relevant articles.
Tech Query: KPIT Technologies, ONGC, Indraprastha Medical Corporation, Everest Kanto Cylinder - What is the outlook? Where are these stocks headed? Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 380.6 INR | 3.9% | 390.2 INR | 355.0 INR | -0.31 | -11.60 | 9.2M | Off |
| 31 Jul 2026 | 366.4 INR | 0.5% | 391.3 INR | 353.5 INR | -0.50 | -14.54 | 811.8K | Off |
| 24 Jul 2026 | 364.6 INR | -1.7% | 394.3 INR | 352.0 INR | -0.41 | -13.05 | 518.3K | Off |
| 17 Jul 2026 | 370.8 INR | -2.6% | 397.3 INR | 350.4 INR | -0.31 | -13.91 | 460.4K | Off |
| 10 Jul 2026 | 380.9 INR | -2.0% | 400.6 INR | 348.7 INR | -0.21 | -11.51 | 631.7K | Off |
| 3 Jul 2026 | 388.6 INR | 0.8% | 403.6 INR | 346.9 INR | -0.22 | -10.28 | 74.0K | Off |
| 26 Jun 2026 | 385.5 INR | 0.7% | 406.5 INR | 345.0 INR | -0.21 | -10.57 | 0 | Off |
| 19 Jun 2026 | 383.0 INR | -0.4% | 410.7 INR | 343.1 INR | -0.10 | -11.12 | 195.1K | Off |
| 12 Jun 2026 | 384.5 INR | -2.9% | 415.1 INR | 341.2 INR | -0.04 | -9.26 | 146.2K | Off |
| 5 Jun 2026 | 396.0 INR | 4.1% | 420.6 INR | 339.3 INR | 0.10 | -5.53 | 192.4K | Off |
| 29 May 2026 | 380.4 INR | 6.0% | 428.1 INR | 337.3 INR | 0.37 | -9.97 | 2.0M | Off |
| 22 May 2026 | 358.8 INR | -2.4% | 435.6 INR | 335.4 INR | 0.43 | -15.82 | 2.0M | Off |
| 15 May 2026 | 367.8 INR | -13.5% | 441.8 INR | 333.7 INR | 0.62 | -13.56 | 2.4M | Off |
| 8 May 2026 | 425.3 INR | 5.8% | 448.1 INR | 331.8 INR | 0.74 | -2.43 | 1.9M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.